About Us

Prince Edward Island BioAlliance

The Prince Edward Island BioAlliance is the private sector-led not-for-profit organization that is responsible for developing and coordinating the strategy for the growth of the Prince Edward Island Bioscience Cluster. Since 2005, the BioAlliance has facilitated the work of businesses, academic and research institutions, and federal and provincial government agencies in establishing the bioscience sector as a key pillar in the economic foundation of the province and Atlantic Canada.

Building from plans developed since 2005, the collaborative model of the BioAlliance has enabled a unique shared vision, an alignment on priorities and strategy, and allocation of resources, that has delivered results. This collaboration has been the driving force of the bio-economy growth to date, and has achieved the PEI Bioscience Cluster recognition as an important element of Canada’s innovation ecosystem.

Our Vision

Canada’s leading catalyst for private-sector-led bioscience-based economic development.

Our strategic priorities include:

  • Attracting new business
  • Job Creation
  • Export revenue growth
  • Investments in R & D
  • Attraction of private capital investments

Our Mission

The PEI BioAlliance coordinates the Cluster of business, academic, research, and government organizations who are dedicated to increasing the economic impact of the bioscience sector in Prince Edward Island.

 

Strategy banner web

PEI BIOSCIENCE CLUSTER STRATEGIC PLAN 2016-2020
Click here to learn more about the PEI BioAlliance growth plan

Screen Shot 2018-05-28 at 10.21.04 AM

TURNING SIZE TO COMPETITIVE ADVANTAGE: THE PEI BIOALLIANCE STORY
Click here to learn more about the BioAlliance story

People and partnerships are core strengths for the Canadian biotechnology industry ecosystem, with regional clusters found in each of the provinces across the country. PEI BioAlliance exemplifies collaboration bringing together academic researchers, clinicians, entrepreneurs, SMEs, investors, and governments.

- Andrew Casey, President and CEO of BIOTECanada